Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Clinical characteristics.
| Characteristics | Patient |
|---|---|
| Gender | Female |
| Age at manifestation | 10 days |
| Follow-up | 2 years |
| Symptom at presentation | Seizure |
| Neurodevelopment | Delayed development milestone |
| Initial serum Mg2+ | 0.9 mg/dl |
| FeMg | 5.8% |
| Follow-up serum Mg2+ | 0.8–1.1 mg/dl |
| Mutation (DNA level) | c.G1439T |
| Mutation (protein level) | p.R480L |
| Zygosity | Heterozygous (de novo) |
| Treatment | Levetiravetam |
| Magnesium oxide (150 mg/kg/day) |
